(Q36454474)

14 August 2017

1 reference

title

Anti-inflammatory properties of Type I interferons (English)

1 reference

14 August 2017

0 references

Alfons Billiau

1

1 reference

14 August 2017

4 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

71

1 reference

14 August 2017

108-116

1 reference

14 August 2017

2-3

1 reference

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

14 August 2017

1 reference

12 December 2020

Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock

1 reference

12 December 2020

Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist

1 reference

12 December 2020

Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta

1 reference

12 December 2020

Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C.

1 reference

12 December 2020

Interferon-induced skin reactivity in man

1 reference

12 December 2020

The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis

1 reference

12 December 2020

Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.

1 reference

12 December 2020

Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy

1 reference

12 December 2020

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

12 December 2020

Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta

1 reference

12 December 2020

An interferon-gamma-related cytokine storm in SARS patients

1 reference

12 December 2020

Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats

1 reference

12 December 2020

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

1 reference

12 December 2020

Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line

1 reference

12 December 2020

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

1 reference

12 December 2020

Human Monocyte-Derived Dendritic Cells Produce Bioactive Gelatinase B: Inhibition by IFN-β

1 reference

12 December 2020

Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy.

1 reference

12 December 2020

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

12 December 2020

Inhibition by interferon of delayed-type hypersensitivity in the mouse

1 reference

12 December 2020

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

1 reference

12 December 2020

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta

1 reference

12 December 2020

Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a.

1 reference

12 December 2020

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

1 reference

12 December 2020

Interferon β-1a downregulates TNFα-induced intercellular adhesion molecule 1 expression on brain microvascular endothelial cells through a tyrosine kinase-dependent pathway

1 reference

12 December 2020

The inhibition of endotoxin-induced local inflammation by LDH virus or LDH virus-infected tumors is mediated by interferon

1 reference

12 December 2020

Interferon and delayed-type hypersensitivity to a viral antigen

1 reference

12 December 2020

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

12 December 2020

Interferon-gamma enhances induction of lymphotoxin in recombinant interleukin 2-stimulated peripheral blood mononuclear cells

1 reference

12 December 2020

Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.

1 reference

12 December 2020

Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens

1 reference

12 December 2020

Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8.

1 reference

12 December 2020

Inhibition of interferon-gamma-induced major histocompatibility complex class II gene transcription by interferon-beta and type beta 1 transforming growth factor in human astrocytoma cells. Definition of cis-element.

1 reference

12 December 2020

Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation.

1 reference

12 December 2020

A comparative trial of recombinant interferon alpha 2A versus alpha 2 beta on myelosuppression in healthy adult volunteers

1 reference

12 December 2020

Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.

1 reference

12 December 2020

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.

1 reference

12 December 2020

Stimulation of transplantation immunity and plasma cell reaction by interferon in mice

1 reference

12 December 2020

Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family

1 reference

12 December 2020

T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells.

1 reference

12 December 2020

Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study.

1 reference

12 December 2020

Proteolytic balance in patients with multiple sclerosis during interferon treatment.

1 reference

12 December 2020

Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment

1 reference

12 December 2020

Recombinant Interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells

1 reference

12 December 2020

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

1 reference

12 December 2020

Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells

1 reference

12 December 2020

Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide

1 reference

12 December 2020

Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

1 reference

12 December 2020

Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells

1 reference

12 December 2020

Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis

1 reference

12 December 2020

Immunosuppressive effects of an interferon preparation in vivo

1 reference

12 December 2020

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.

1 reference

12 December 2020

Inhibition of Passive Localized Experimental Allergic Encephalomyelitis by Interferon

1 reference

12 December 2020

Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis.

1 reference

12 December 2020

The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8

1 reference

12 December 2020

Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C.

1 reference

12 December 2020

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

12 December 2020

Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis

1 reference

12 December 2020

Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta

1 reference

12 December 2020

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

12 December 2020

Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption.

1 reference

12 December 2020

Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

1 reference

12 December 2020

IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cell

1 reference

12 December 2020

Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha.

1 reference

12 December 2020

IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells

1 reference

12 December 2020

Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons

1 reference

12 December 2020

Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

1 reference

12 December 2020

Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection

1 reference

12 December 2020

Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Infection of mice with lactic dehydrogenase virus prevents development of experimental allergic encephalomyelitis

1 reference

12 December 2020

Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat.

1 reference

12 December 2020

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis by interferon

1 reference

12 December 2020

Inhibition of the Acute Inflammatory Response by Interferon Inhibitors

1 reference

12 December 2020

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.

1 reference

12 December 2020

Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma

1 reference

12 December 2020

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

12 December 2020

Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage.

1 reference

12 December 2020

In vitro modulation of adhesion molecules, adhesion phenomena, and fluid phase endocytosis on human umbilical vein endothelial cells and brain-derived microvascular endothelium by IFN-beta 1a.

1 reference

12 December 2020

Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells

1 reference

12 December 2020

Electrophoretically pure mouse interferon exerts multiple biologic effects

1 reference

12 December 2020

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

12 December 2020

Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy

1 reference

12 December 2020

Immuno-modulating properties of interferons

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2006.03.006

Identifiers

DOI

1 reference

14 August 2017

0 references

1 reference

PubMed ID

16626815